Episode 36
Tirzepatide vs Retatrutide: Why David Switched
David tried the standard weekly shot, which works on two pathways, and watched his muscle go down with the fat. His story explains the newer three-pathway design and why he switched.

Now playing · Episode 36
Tirzepatide vs Retatrutide: Why David Switched
Transcript
- David was the guy at the gym before work.
- Five days a week.
- Then the years caught up.
- The weight crept on.
- The runs got slower.
- He tried diets.
- He tried fasting.
- The weight kept winning.
- So he tried the standard weekly shot.
- The scale moved.
- 20 pounds in four months.
- But something else moved with it.
- His arms got thinner.
- Not leaner.
- Thinner.
- He'd benched 185 for 10 years.
- Now he couldn't get six reps.
- His face looked drawn.
- His shoulders looked smaller.
- His clothes hung off him in a way that didn't look right.
- He was losing weight.
- He was also losing himself.
- His doctor flagged it on the body comp scan.
- The fat was coming down.
- But the muscle was going down faster.
- He was getting smaller.
- Not stronger.
- Then a colleague mentioned a different protocol.
- Same family.
- Different mechanism.
- The standard shot works on two pathways.
- The newer one works on three.
- The third one tells the body to burn fat for fuel.
- Instead of pulling apart muscle.
- David switched.
- Week by week the scale kept moving.
- But the mirror told a different story.
- His arms held.
- His chest came back.
- His benchmark lifts started climbing.
- His energy came back.
- He stopped feeling drained at three in the afternoon.
- His face filled back in.
- He stopped looking sick.
- He was lighter.
- He was also stronger.
- So what did David do?
- He visited readypep.com and ordered his pen.
- It came with free lifetime guidance and free shipping.
- What are you waiting for?